Pharmaceutical Executive May 10, 2021
The COVID-19 pandemic has shined a spotlight on the importance of maintaining a robust global pharmaceutical supply chain. But combating the novel coronavirus is only one of the reasons we need a more effective, sustainable system for manufacturing and distributing the drugs the world needs. A critical element in keeping healthy supply chains is addressing the release of pharmaceuticals in the environment (PiE) and the interlinked potential for the emergence of antimicrobial resistance (AMR).
Most pharmaceuticals enter the environment as patients use and dispose of the medicines they consume. But the drug manufacturing process can also release emissions into the environment, primarily through discharges that elevate concentrations of pharmaceuticals downstream from production facilities.
For example, manufacturing facilities that don’t adhere...
Today's Sponsors
Today's Sponsor